Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly L Fischer

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Urology Practice|August 4, 2023
Improving Clinic Productivity through a Shared Medical AppointmentKimberly L Fischer, Matthew S Christman
The Journal of Pharmacology and Experimental Therapeutics|July 14, 2009
Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitorsMark R Swingle, Lauren Amable, Brian G Lawhorn, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Urology Practice|August 4, 2023
Improving Clinic Productivity through a Shared Medical AppointmentKimberly L Fischer, Matthew S Christman
The Journal of Pharmacology and Experimental Therapeutics|July 14, 2009
Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitorsMark R Swingle, Lauren Amable, Brian G Lawhorn, et al.
Pageof 1